21. Not until the regulatory committee meticulously reviewed the newly submitted clinical trial data ______ the pharmaceutical conglomerate to resume the production of its controversial medical device.
(A) they allowed
(B) did they allow
(C) the committee allowed
(D) was allowed

答案：登入後查看
統計： A(0), B(2), C(0), D(0), E(0) #4070164